Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AMS's antibacterial foam dressings get US OK

This article was originally published in Clinica

Executive Summary

The silver-impregnated polyurethane foam dressings developed by Advanced Medical Solutions (AMS) have been granted 510(k) clearance by the US FDA. AMS is seeking a suitable partner to commercialise the products in the US. The dressings employ foam from Corpura, a Dutch company part-owned by AMS, and have been approved for the management of partial-to-full thickness wounds with light-to-moderate exudate. These include pressure sores, diabetic ulcers, leg ulcers, graft and donor sites, lacerations and abrasions, first and second degree burns, trauma wounds and post-operative surgical wounds. AMS (Winsford, UK) acquired 49.4% ownership of Etten-Leur-based Corpura in May 2008.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044053

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel